Cited by 2,797Angiogenesis and VEGF in CancerProtease and Inhibitor MechanismsTGF-β signaling in diseases

The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.

Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis

Open access

Bergers, Gabriele, Brekken, Rolf, McMahon, Gerald, Vu, Thiennu H., Itoh, Takeshi, Tamaki, Kazuhiko, Tanzawa, Kazuhiko, Thorpe, Philip, Itohara, Shigeyoshi, Werb, Zena, Hanahan, Douglas·2000·Nature Cell Biology

DOI 10.1038/35036374PMC PMC2852586

Open this paper in CoChat — free account

Abstract

During carcinogenesis of pancreatic islets in transgenic mice, an angiogenic switch activates the quiescent vasculature. Paradoxically, vascular endothelial growth factor (VEGF) and its receptors are expressed constitutively. Nevertheless, a synthetic inhibitor (SU5416) of VEGF signalling impairs angiogenic switching and tumour growth. Two metalloproteinases, MMP-2/gelatinase-A and MMP-9/gelatinase-B, are upregulated in angiogenic lesions. MMP-9 can render normal islets angiogenic, releasing VEGF. MMP inhibitors reduce angiogenic switching, and tumour number and growth, as does genetic ablation of MMP-9. Absence of MMP-2 does not impair induction of angiogenesis, but retards tumour growth, whereas lack of urokinase has no effect. Our results show that MMP-9 is a component of the angiogenic switch.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1038/35036374

Cites

45 of 45 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The hallmarks of cancer
Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219
Self-citation
Tumor angiogenesis: therapeutic implications
Sherwood, L. M., Parris, E. E., & Folkman, J. (1971) · New England Journal of Medicine · doi:10.1056/nejm197111182852108 · Cited by 10,187
Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis
Hanahan, D., & Folkman, J. (1996) · Cell · doi:10.1016/s0092-8674(00)80108-7 · Cited by 6,885
Self-citation
Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele
Carmeliet, P., Ferreira, V., Breier, G., Pollefeyt, S., Kieckens, L., Gertsenstein, M., Fahrig, M., Vandenhoeck, A., Harpal, K., Eberhardt, C., et al. (1996) · Nature · doi:10.1038/380435a0 · Cited by 4,162
Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene
Ferrara, N., Carver-Moore, K., Chen, H., Dowd, M., Lu, L., O’Shea, K. S., Powell-Braxton, L., Hillan, K. J., & Moore, M. W. (1996) · Nature · doi:10.1038/380439a0 · Cited by 3,661
Transplacental Carcinogenesis by Stilbestrol
Folkman, J. (1971) · New England Journal of Medicine · doi:10.1056/nejm197108122850711 · Cited by 2,640
VEGF couples hypertrophic cartilage remodeling, ossification and angiogenesis during endochondral bone formation
Gerber, H. P., Vu, T. H., Ryan, A. M., Kowalski, J., Werb, Z., & Ferrara, N. (1999) · Nature Medicine · doi:10.1038/9467 · Cited by 2,107
Self-citation
Cell surface-localized matrix metalloproteinase-9 proteolytically activates TGF-beta and promotes tumor invasion and angiogenesis.
Yu, Q., & Stamenkovic, I. (2000) · PubMed · Cited by 1,952
Induction of angiogenesis during the transition from hyperplasia to neoplasia
Folkman, J., Watson, K., Ingber, D., & Hanahan, D. (1989) · Nature · doi:10.1038/339058a0 · Cited by 1,879
Self-citation
Cell surface-localized matrix metalloproteinase-9 proteolytically activates TGF-β and promotes tumor invasion and angiogenesis
Yu, Q., & Stamenkovic, I. (2000) · Genes & Development · doi:10.1101/gad.14.2.163 · Cited by 1,754

Flagged first, then by citations

Show all 45 references

Sorted by citations

Items 301–400 of 1,009

Proteomics Discovery of Metalloproteinase Substrates in the Cellular Context by iTRAQ™ Labeling Reveals a Diverse MMP-2 Substrate Degradome
Dean, R. A., & Overall, C. M. (2007) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m600341-mcp200 · Cited by 239
The cell surface: the stage for matrix metalloproteinase regulation of migration
Seiki, M. (2002) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(02)00363-0 · Cited by 230
Matrix Metalloproteinases: A challenging paradigm of cancer management
Alaseem, A. M., Alhazzani, K., Dondapati, P., Alobid, S. E., Bishayee, A., & Rathinavelu, A. (2017) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2017.11.008 · Cited by 237
The tumor microenvironment: a critical determinant of neoplastic evolution
van Kempen, L. C. L. T., Ruiter, D. J., van Muijen, G. N. P., & Coussens, L. M. (2003) · European Journal of Cell Biology · doi:10.1078/0171-9335-00346 · Cited by 231
Podoplanin-Expressing Macrophages Promote Lymphangiogenesis and Lymphoinvasion in Breast Cancer
Bieniasz-Krzywiec, P., Martín‐Pérez, R., Ehling, M., García‐Caballero, M., Pinioti, S., Pretto, S., Kroes, R., Aldeni, C., Matteo, M. D., Prenen, H., et al. (2019) · Cell Metabolism · doi:10.1016/j.cmet.2019.07.015 · Cited by 227
“In tumors, matrix remodeling and MMPs offer new paths for migration and invasion but also allow the release of growth factors that otherwisewould remain bound tomatrix components, the cell surface, or sequestered by growth factor binding proteins (Bergers et al., 2000;Mott andWerb, 2004).”
Background
Angiogenesis Is Required for Successful Bone Induction During Distraction Osteogenesis
Fang, T. D., Salim, A., Xia, W., Nacamuli, R. P., Guccione, S., Song, H. M., Carano, R. A. D., Filvaroff, E. H., Bednarski, M. D., Giaccia, A. J., et al. (2005) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.050301 · Cited by 230
An Alternate Perspective on the Roles of TIMPs and MMPs in Pathology
Moore, C. S., & Crocker, S. J. (2011) · American Journal Of Pathology · doi:10.1016/j.ajpath.2011.09.008 · Cited by 236
Predicting benefit from anti-angiogenic agents in malignancy
Jubb, A. M., Oates, A., Holden, S. N., & Koeppen, H. (2006) · Nature reviews. Cancer · doi:10.1038/nrc1946 · Cited by 232
Fibroblast growth factors are required for efficient tumor angiogenesis.
Compagni, A., Wilgenbus, P., Impagnatiello, M.-A., Cotten, M. L., & Christofori, G. (2000) · PubMed · Cited by 227
Mammalian heparanase: involvement in cancer metastasis, angiogenesis and normal development
Vlodavsky, I., Goldshmidt, O., Zcharia, E., Atzmon, R., Guatta-Rangini, Z., Elkin, M., Peretz, T., & Friedmann, Y. (2002) · Seminars in Cancer Biology · doi:10.1006/scbi.2001.0420 · Cited by 226
Distinct mechanisms of TGF- 1-mediated epithelial-to-mesenchymal transition and metastasis during skin carcinogenesis
Han, G. (2005) · Journal of Clinical Investigation · doi:10.1172/jci24399 · Cited by 224
Spontaneous and genetically engineered animal models
Hansen, K., & Khanna, C. (2004) · European Journal of Cancer · doi:10.1016/j.ejca.2003.11.031 · Cited by 226
The Low Density Lipoprotein Receptor-related Protein Modulates Levels of Matrix Metalloproteinase 9 (MMP-9) by Mediating Its Cellular Catabolism
Hahn-Dantona, E. A., Ruiz, J. F., BORNSTEIN, P. K., & Strickland, D. K. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m100121200 · Cited by 227
Invasion and metastasis in pancreatic cancer.
Keleg, S., Büchler, P., Ludwig, R., Büchler, M. W., & Frieß, H. (2003) · Molecular Cancer · doi:10.1186/1476-4598-2-14 · Cited by 222
Neurofibromin-deficient Schwann cells secrete a potent migratory stimulus for Nf1+/– mast cells
Yang, F., Ingram, D. A., Shi, C., Hingtgen, C. M., Ratner, N., Monk, K. R., Clegg, T., White, H. A., Mead, L. E., Wenning, M. J., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci19195 · Cited by 221
HSulf-2, an extracellular endoglucosamine-6-sulfatase, selectively mobilizes heparin-bound growth factors and chemokines: effects on VEGF, FGF-1, and SDF-1
Uchimura, K., Morimoto‐Tomita, M., Bistrup, A., Li, J., Lyon, M., Gallagher, J. T., Werb, Z., & Rosen, S. D. (2006) · BMC Biochemistry · doi:10.1186/1471-2091-7-2 · Cited by 236
Self-citation
Deficiency of the Cysteine Protease Cathepsin S Impairs Microvessel Growth
Shi, G., Sukhova, G. K., Kuzuya, M., Ye, Q., Du, J., Zhang, Y., Pan, J., Lu, M. L., Cheng, X. W., Iguchi, A., et al. (2003) · Circulation Research · doi:10.1161/01.res.0000060485.20318.96 · Cited by 221
FRA-1 expression level regulates proliferation and invasiveness of breast cancer cells
Belguise, K., Kersual, N., Galtier, F., & Chalbos, D. (2004) · Oncogene · doi:10.1038/sj.onc.1208312 · Cited by 219
Contribution of endothelial progenitors and proangiogenic hematopoietic cells to vascularization of tumor and ischemic tissue
Kopp, H., Ramos, C. A., & Rafii, S. (2006) · Current Opinion in Hematology · doi:10.1097/01.moh.0000219664.26528.da · Cited by 221
Three small integrin‐binding ligand N‐linked glycoproteins (SIBLINGs) bind and activate specific matrix metalloproteinases
Fedarko, N. S., Jain, A., Karadağ, A., & Fisher, L. W. (2004) · The FASEB Journal · doi:10.1096/fj.03-0966fje · Cited by 220
The expression of matrix metalloproteinase-2 and-9 in human gliomas of different pathological grades
Wang, M., Wang, T., Liu, S., Yoshida, D., & Teramoto, A. (2003) · Brain Tumor Pathology · doi:10.1007/bf02483449 · Cited by 220
Integrin β4 signaling promotes tumor angiogenesis
Nikolopoulos, S. N., Blaikie, P., Yoshioka, T., Guo, W., & Giancotti, F. G. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.09.029 · Cited by 221
Semaphorin 3A is an endogenous angiogenesis inhibitor that blocks tumor growth and normalizes tumor vasculature in transgenic mouse models
Maione, F., Molla, F., Meda, C., Latini, R., Zentilin, L., Giacca, M., Seano, G., Serini, G., Bussolino, F., & Giraudo, E. (2009) · Journal of Clinical Investigation · doi:10.1172/jci36308 · Cited by 227
Immune activation and chronic inflammation as the cause of malignancy in oral lichen planus: is there any evidence ?
Mignogna, M. D., Fedele, S., Russo, L. L., Muzio, L. L., & Bucci, E. (2003) · Oral Oncology · doi:10.1016/j.oraloncology.2003.08.001 · Cited by 220
Molecular mechanism of pancreatic tumor metastasis inhibition by Gd@C 82 (OH) 22 and its implication for de novo design of nanomedicine
Kang, S.-G., Zhou, G., Yang, P. X., Liu, Y., Sun, B., Huynh, T., Meng, H., Zhao, L., Xing, G., Chen, C., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1204600109 · Cited by 218
Stromal Matrix Metalloproteinase-9 Regulates the Vascular Architecture in Neuroblastoma by Promoting Pericyte Recruitment
Chantrain, C. F., Shimada, H., Jodele, S., Groshen, S. G., Ye, W., Shalinsky, D. R., Werb, Z., Coussens, L. M., & DeClerck, Y. A. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-0160 · Cited by 217
Self-citation
Innate Immunity and Cancer Pathophysiology
Maiorino, L., Daßler‐Plenker, J., Sun, L., & Egeblad, M. (2021) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev-pathmechdis-032221-115501 · Cited by 233
R Regulation of tumor angiogenesis and metastasis by FGF and PDGF signaling pathways
Cao, Y., Cao, R., & Hedlund, E. (2008) · Journal of Molecular Medicine · doi:10.1007/s00109-008-0337-z · Cited by 217
Chemoresistance and the Self-Maintaining Tumor Microenvironment
Yeldag, G., Rice, A. J., & Hernández, A. E. D. R. (2018) · Cancers · doi:10.3390/cancers10120471 · Cited by 222
“MMPs further release VEGF sequestered in the ECM to promote vascularization [232], and the deposition of high amounts of ECM proteins contributes to interstitial fluid pressure, as negatively charged hyaluronan chains promote the immobilization of liquid [233].”
Background
Multiphasic roles for matrix metalloproteinases after stroke
ROSELL, A., & LO, E. (2008) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2007.12.001 · Cited by 215
VEGF release by MMP-9 mediated heparan sulphate cleavage induces colorectal cancer angiogenesis
Hawinkels, L. J. A. C., Zuidwijk, K., Verspaget, H. W., de Jonge‐Muller, E. S. M., van Duijn, W., Ferreira, V., Fontijn, R. D., David, G., Hommes, D. W., Lamers, C. B. H. W., et al. (2008) · European Journal of Cancer · doi:10.1016/j.ejca.2008.06.031 · Cited by 212
Roles of Matrix Metalloproteinases and Their Natural Inhibitors in Prostate Cancer Progression
Gong, Y., Chippada-Venkata, U., & Oh, W. K. (2014) · Cancers · doi:10.3390/cancers6031298 · Cited by 223
Cancer Metabolism and Elevated O-GlcNAc in Oncogenic Signaling
Ma, Z., & Vosseller, K. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.r114.577718 · Cited by 218
“MMP-9 has also been shown to be important in liberating matrix-bound VEGF-A in mouse models (75).”
Background
The Great Escape; the Hallmarks of Resistance to Antiangiogenic Therapy
B, J. R. V. B., Nowak-Sliwinska, P. M., Huijbers, E. J. M., Thijssen, V. L., & Griffioen, A. W. (2015) · Pharmacological Reviews · doi:10.1124/pr.114.010215 · Cited by 211
“(MMPs), which results in extracellular matrix degradation and release of matrix-sequestered growth factors that can promote angiogenesis and tumor growth (Bergers et al., 2000; Coussens and Werb, 2002; Huang et al., 2002; Mantovani et al., 2002).”
Background
Matrix metalloproteinase inhibitors (MMPIs): The beginning of phase I or the termination of phase III clinical trials
Pavlaki, M., & Zucker, S. (2003) · Cancer and Metastasis Reviews · doi:10.1023/a:1023047431869 · Cited by 212
Ellagic acid, a phenolic compound, exerts anti-angiogenesis effects via VEGFR-2 signaling pathway in breast cancer
Wang, N., Wang, Z., Mo, S., Loo, T. Y., Wang, D.-M., Luo, H., Yang, D., Chen, Y., Shen, J., & Chen, J. (2012) · Breast Cancer Research and Treatment · doi:10.1007/s10549-012-1977-9 · Cited by 221
Navigating ECM Barriers at the Invasive Front: The Cancer Cell–Stroma Interface
Rowe, R. G., & Weiss, S. J. (2009) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.24.110707.175315 · Cited by 214
Leukocytes in Mammary Development and CancerPreprint
Coussens, L. M., & Pollard, J. W. (2010) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a003285 · Cited by 214
Genetically Engineered Mouse Models in Cancer Research
Walrath, J. C., Hawes, J. J., Dyke, T. V., & Reilly, K. M. (2010) · Advances in cancer research · doi:10.1016/s0065-230x(10)06004-5 · Cited by 222
Gelatinase B/MMP-9 in Tumour Pathogenesis and Progression
Farina, A. R., & Mackay, A. R. (2014) · Cancers · doi:10.3390/cancers6010240 · Cited by 215
“Gelatinase B/MMP-9 also triggers ―the angiogenic switch‖ by mobilising and activating angiogenic mitogens from matrix stores at the onset of tumour-associated angiogenesis [169,211,251,253].”
BackgroundInfluential
Extracellular Matrix Modulates Angiogenesis in Physiological and Pathological Conditions
Neve, A., Cantatore, F. P., Maruotti, N., Corrado, A., & Ribatti, D. (2014) · BioMed Research International · doi:10.1155/2014/756078 · Cited by 207
The Axl receptor tyrosine kinase confers an adverse prognostic influence in pancreatic cancer and represents a new therapeutic target
Koorstra, J.-B. M., Karikari, C. A., Feldmann, G., Bisht, S., Rojas, P. L., Offerhaus, G. J. A., Alvarez, H., & Maitra, A. (2009) · Cancer Biology & Therapy · doi:10.4161/cbt.8.7.7923 · Cited by 208
TrkA alternative splicing
Tacconelli, A., Farina, A. R., Cappabianca, L. A., DeSantis, G., Tessitore, A., Vetuschi, A., Sferra, R., Rucci, N., Argenti, B., Screpanti, I., et al. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.09.011 · Cited by 217
Manipulating angiogenesis in medicine
Carmeliet, P. (2004) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2003.01297.x · Cited by 215
Proteinases in cutaneous wound healing
Toriseva, M., & Kähäri, V. (2008) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-008-8388-4 · Cited by 220
Matrix metalloproteinases: protective roles in cancer
Decock, J. V., Thirkettle, S., Wagstaff, L., & Edwards, D. R. (2011) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2011.01302.x · Cited by 209
Role of hepatic resident and infiltrating macrophages in liver repair after acute injury
You, Q., Holt, M. R., Yin, H., Li, G., Hu, C., & Ju, C. (2013) · Biochemical Pharmacology · doi:10.1016/j.bcp.2013.07.006 · Cited by 205
Neutrophils in cancer
Treffers, L. W., Hiemstra, I. H., Kuijpers, T. W., van den Berg, T. K., & Matlung, H. L. (2016) · Immunological Reviews · doi:10.1111/imr.12444 · Cited by 211
Neutrophil extracellular traps: protagonists of cancer progression?
Erpenbeck, L., & Schön, M. P. (2017) · Oncogene · doi:10.1038/onc.2016.406 · Cited by 199
Cardiovascular Actions of Neurotrophins
Caporali, A., & Emanueli, C. (2009) · Physiological Reviews · doi:10.1152/physrev.00007.2008 · Cited by 210
Selective Allosteric Inhibition of MMP9 Is Efficacious in Preclinical Models of Ulcerative Colitis and Colorectal Cancer
Marshall, D. C. L., Lyman, S. K., McCauley, S., Kovalenko, M. A., Spangler, R., Liu, C., Lee, M., O’Sullivan, C., Barry-Hamilton, V., Ghermazien, H., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0127063 · Cited by 198
“The observed difference in anti-metastases efficacy is consistent with evidence supporting a prominent role for stromal MMP9 in metastatic growth [65, 70, 73, 96, 97].”
Result
Matrix Metalloproteinase-9 from Bone Marrow–Derived Cells Contributes to Survival but not Growth of Tumor Cells in the Lung Microenvironment
Acuff, H. B., Carter, K. J., Fingleton, B., Gorden, D. L., & Matrisian, L. M. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-2502 · Cited by 202
Endogenous MMP-9 and not MMP-2 promotes rheumatoid synovial fibroblast survival, inflammation and cartilage degradation
Xue, M., McKelvey, K. J., Shen, K., Minhas, N., MARCH, L. M., Park, S., & Jackson, C. (2014) · Lara D. Veeken · doi:10.1093/rheumatology/keu254 · Cited by 200
The Myc-dependent angiogenic switch in tumors is mediated by interleukin 1βPreprint
Shchors, K., Shchors, E., Rostker, F., Lawlor, E. R., Swigart, L. B., & Evan, G. I. (2006) · Genes & Development · doi:10.1101/gad.1455706 · Cited by 204
Macrophages Mediate Inflammation-Enhanced Metastasis of Ovarian Tumors in Mice
Robinson-Smith, T. M., Isaacsohn, I., Mercer, C. A., Zhou, M., van Rooijen, N., Husseinzadeh, N., McFarland-Mancini, M. M., & Drew, A. F. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-4375 · Cited by 205
Differential Expression of the Angiogenic Factor Genes Vascular Endothelial Growth Factor (VEGF) and Endocrine Gland-Derived VEGF in Normal and Polycystic Human Ovaries
Ferrara, N., Frantz, G. D., LeCouter, J. E., Dillard‐Telm, L., Pham, T., Draksharapu, A., Giordano, T. J., & Peale, F. V., Jr. (2003) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64322-2 · Cited by 198
Absence of lymphangiogenesis and intratumoural lymph vessels in human metastatic breast cancer
Williams, C. S. M., Leek, R., Robson, A., Banerji, S., Prevo, R., Harris, A. L., & Jackson, D. G. (2003) · The Journal of Pathology · doi:10.1002/path.1343 · Cited by 198
Identification of Candidate Angiogenic Inhibitors Processed by Matrix Metalloproteinase 2 (MMP-2) in Cell-Based Proteomic Screens: Disruption of Vascular Endothelial Growth Factor (VEGF)/Heparin Affin Regulatory Peptide (Pleiotrophin) and VEGF/Connective Tissue Growth Factor Angiogenic Inhibitory Complexes by MMP-2 Proteolysis
Dean, R. A., Butler, G. S., Hamma‐Kourbali, Y., Delbé, J., Brigstock, D. R., Courty, J., & Overall, C. M. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.00821-07 · Cited by 199
Matrix Metalloproteinases Contribute Distinct Roles in Neuroendocrine Prostate Carcinogenesis, Metastasis, and Angiogenesis Progression
Littlepage, L. E., Sternlicht, M. D., Rougier, N., Phillips, J. J., Gallo, E., Yu, Y., Williams, K., Brenot, A., Gordon, J. I., & Werb, Z. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-3515 · Cited by 200
Self-citation
Functional Haplotypes in the Promoter of Matrix Metalloproteinase-2 Predict Risk of the Occurrence and Metastasis of Esophageal Cancer
Yu, C.-Y., Zhou, Y., Miao, X., Xiong, P., Tan, W., & Lin, D. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-1521 · Cited by 197
Pro-MMP-9 activation by the MT1-MMP/MMP-2 axis and MMP-3: role of TIMP-2 and plasma membranes
Tóth, M., Chvyrkova, I., Bernardo, M. M., Hernandez‐Barrantes, S., & Fridman, R. A. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(03)01405-0 · Cited by 196
Positive Feedback Regulation between MMP-9 and VEGF in Human RPE Cells
Hollborn, M., Stathopoulos, C., Steffen, A., Wiedemann, P., Kohen, L., & Bringmann, A. (2007) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.06-1234 · Cited by 199
Why is Parity Protective for Uterine Fibroids?
Baird, D. D., & Dunson, D. B. (2003) · Epidemiology · doi:10.1097/01.ede.0000054360.61254.27 · Cited by 196
Matrix Metalloproteinases in Inflammatory Bowel Disease: An Update
O’Sullivan, S., Gilmer, J. F., & Medina, C. (2015) · Mediators of Inflammation · doi:10.1155/2015/964131 · Cited by 206
“The ability of MMP-9 to release bound VEGF-A and alter its angiogenic outcome [125, 126] was not assessed in the context of IBD in the studies described; however, serum MMP-9 levels were found to correlate with serum VEGF in CD but not UC patients [127].”
Background
Inhibition of Angiogenesis and Invasion by 3,3′-Diindolylmethane Is Mediated by the Nuclear Factor–κB Downstream Target Genes MMP-9 and uPA that Regulated Bioavailability of Vascular Endothelial Growth Factor in Prostate Cancer
Kong, D., Li, Y., Wang, Z. P., Banerjee, S., & Sarkar, F. H. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-4277 · Cited by 196
Retracted
Matrix metalloproteinase-2 and -9 as promising benefactors in development, plasticity and repair of the nervous system
Verslegers, M., Lemmens, K., Hove, I. V., & Moons, L. (2013) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2013.03.004 · Cited by 202
Pathobiology of brain metastases: Table 1
Nathoo, N., Chahlavi, A., Barnett, G. H., & Toms, S. A. (2005) · Journal of Clinical Pathology · doi:10.1136/jcp.2003.013623 · Cited by 195
Mechanisms of endothelial cell migration
Michaelis, U. R. (2014) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-014-1678-0 · Cited by 202
“The extracellular matrix has the capacity to store pro-angiogenic chemokines and cytokines, such as VEGF, that are released upon MMP activation [96, 97].”
Background
Substrate Hydrolysis by Matrix Metalloproteinase-9*
Kridel, S. J., Chen, E., Kotra, L. P., Howard, E. W., Mobashery, S., & Smith, J. W. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m100900200 · Cited by 192
Pericellular proteolysis in cancerPreprint
Sevenich, L., & Joyce, J. A. (2014) · Genes & Development · doi:10.1101/gad.250647.114 · Cited by 198
“VEGF isoform spatial distribution is mediated by both interactions with HSPGs in the ECM and proteases such as plasmin and a subset of MMPs that can cleave ECM components and the C-terminal regions of VEGF to release the biologically active growth factor from the ECM (Baker et al. 2000; Bergers et al. 2000; Lee et al.…”
Background
Making the cut: Protease-mediated regulation of angiogenesis
Roy, R., Zhang, B., & Moses, M. A. (2006) · Experimental Cell Research · doi:10.1016/j.yexcr.2005.11.022 · Cited by 191
How Proteases Regulate Bone Morphogenesis
Ortéga, N., Behonick, D. J., Stickens, D., & Werb, Z. (2003) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2003.tb03214.x · Cited by 194
Self-citation
Signaling Pathways Governing Tumor Angiogenesis
Sakurai, T., & Kudo, M. (2011) · Oncology · doi:10.1159/000333256 · Cited by 193
MMP‐2 and MMP‐9 synergize in promoting choroidal neovascularization
Lambert, V., Wielockx, B., Munaut, C., Galopin, C., Jost, M., Itoh, T., Werb, Z., Baker, A. H., Libert, C., Krell, H., et al. (2003) · The FASEB Journal · doi:10.1096/fj.03-0113fje · Cited by 195
Self-citation
Osteoclasts are important for bone angiogenesis
Cackowski, F. C., Anderson, J. L., Patrene, K. D., Choksi, R. J., Shapiro, S. D., Windle, J. J., Blair, H. C., & Roodman, G. D. (2010) · Blood · doi:10.1182/blood-2009-08-237628 · Cited by 188
VEGF inhibition: insights from preclinical and clinical studies
Crawford, Y., & Ferrara, N. (2008) · Cell and Tissue Research · doi:10.1007/s00441-008-0675-8 · Cited by 192
Angiogenesis: vascular remodeling of the extracellular matrix involves metalloproteinases
Heissig, B., Hattori, K., Friedrich, M., Rafii, S., & Werb, Z. (2003) · Current Opinion in Hematology · doi:10.1097/00062752-200303000-00007 · Cited by 190
Self-citation
Neutrophils as a key cellular target for angiostatin: implications for regulation of angiogenesis and inflammation
Benelli, R., Morini, M., Carrozzino, F., Ferrari, N., Minghelli, S., Santi, L., Cassatella, M. A., Noonan, D. M., & Albini, A. (2001) · The FASEB Journal · doi:10.1096/fj.01-0651fje · Cited by 188
Early events in HSV keratitis—setting the stage for a blinding disease
Biswas, P. S., & Rouse, B. T. (2005) · Microbes and Infection · doi:10.1016/j.micinf.2005.03.003 · Cited by 187
Toward the biomimetic implant surface: Biopolymers on titanium-based implants for bone regeneration
Tejero, R., Anitua, E., & Orive, G. (2014) · Progress in Polymer Science · doi:10.1016/j.progpolymsci.2014.01.001 · Cited by 190
Thrombospondins as key regulators of synaptogenesis in the central nervous system
Risher, W. C., & Eroğlu, Ç. (2012) · Matrix Biology · doi:10.1016/j.matbio.2012.01.004 · Cited by 186
Next generation matrix metalloproteinase inhibitors — Novel strategies bring new prospects
Levin, M., Udi, Y., Solomonov, I., & Sagi, I. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2017.06.009 · Cited by 186
Protein Kinase C-ζ Regulates Transcription of the Matrix Metalloproteinase-9 Gene Induced by IL-1 and TNF-α in Glioma Cells via NF-κB
Esteve, P. O., Chicoine, É., Robledo, O., Aoudjit, F., Descoteaux, A., Potworowski, É. F., & St‐Pierre, Y. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m108600200 · Cited by 187
Biological significance of c-erbB family oncogenes in head and neck cancer
Rogers, S. J., Harrington, K. J., Rhys‐Evans, P. H., O‐charoenrat, P., & Eccles, S. A. (2005) · Cancer and Metastasis Reviews · doi:10.1007/s10555-005-5047-1 · Cited by 184
Matrix Metalloproteinase-9 Is Required for Adequate Angiogenic Revascularization of Ischemic Tissues
Johnson, C., Sung, H., Lessner, S. M., Fini, M. E., & Galis, Z. S. (2003) · Circulation Research · doi:10.1161/01.res.0000111527.42357.62 · Cited by 184
Activation of tumor cell integrin α v β 3 controls angiogenesis and metastatic growth in the brain
Lorger, M., Krueger, J. S., O’Neal, M. A., Staflin, K., & Felding‐Habermann, B. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0903035106 · Cited by 185
Hypoxia Inducible Factor-1–Independent Pathways in Tumor Angiogenesis
Mizukami, Y., Kohgo, Y., & Chung, D. C. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-0111 · Cited by 189
Endothelial???stromal interactions in angiogenesis
Hughes, C. C. W. (2008) · Current Opinion in Hematology · doi:10.1097/moh.0b013e3282f97dbc · Cited by 188
Biophysical models of tumour growth
Tracqui, P. (2009) · Reports on Progress in Physics · doi:10.1088/0034-4885/72/5/056701 · Cited by 191
Matrix metalloproteinases and bone
Krane, S. M., & Inada, M. (2008) · Bone · doi:10.1016/j.bone.2008.03.020 · Cited by 181
Contribution of host MMP‐2 and MMP‐9 to promote tumor vascularization and invasion of malignant keratinocytes
Masson, V., de la Ballina, L. R., Munaut, C., Wielockx, B., Jost, M., Maillard, C., Blacher, S., Bajou, K., Itoh, T., Itohara, S., et al. (2004) · The FASEB Journal · doi:10.1096/fj.04-2140fje · Cited by 190
Self-citation
The VEGF family in cancer and antibody-based strategies for their inhibition
Sullivan, L. A., & Brekken, R. A. (2010) · mAbs · doi:10.4161/mabs.2.2.11360 · Cited by 184
Self-citation
Urinary Biomarkers Predict Brain Tumor Presence and Response to Therapy
Smith, E. R., Zurakowski, D., Saad, A. G., Scott, R. M., & Moses, M. A. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-1253 · Cited by 182
Myeloid Cells in the Tumor Microenvironment: Modulation of Tumor Angiogenesis and Tumor Inflammation
Schmid, M. C., & Varner, J. A. (2010) · Journal of Oncology · doi:10.1155/2010/201026 · Cited by 191
Immune Enhancement of Skin Carcinogenesis by CD4+ T Cells
Daniel, D., Meyer-Morse, N., Bergsland, E. K., Dehne, K., Coussens, L. M., & Hanahan, D. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20021047 · Cited by 180
Self-citation
Corneal Neovascularization and the Utility of Topical VEGF Inhibition: Ranibizumab (Lucentis) Vs Bevacizumab (Avastin)
STEVENSON, W. C., Cheng, S.-F., Dastjerdi, M. H., Ferrari, G., & Dana, R. (2012) · The Ocular Surface · doi:10.1016/j.jtos.2012.01.005 · Cited by 185
Garcinol: Current status of its anti-oxidative, anti-inflammatory and anti-cancer effects
Liu, C., Ho, P. C., Wong, F. C., Sethi, G., Wang, L. Z., & Goh, B. C. (2015) · Cancer Letters · doi:10.1016/j.canlet.2015.03.019 · Cited by 185
Distinct Functions of Neutrophil in Cancer and Its Regulation
Granot, Z., & Jabłońska, J. (2015) · Mediators of Inflammation · doi:10.1155/2015/701067 · Cited by 181
Interleukin-17–Producing Neutrophils Link Inflammatory Stimuli to Disease Progression by Promoting Angiogenesis in Gastric Cancer
Li, T.-J., Jiang, Y.-M., Hu, Y.-F., Huang, L., Yu, J., Zhao, L.-Y., Deng, H.-J., Mou, T.-Y., Liu, H., Yang, Y., et al. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-16-0617 · Cited by 179
“Peritumoral stromal neutrophils promote angiogenesis at the invasive margin via MMP-9 signaling MMP-9 participates in tumor development by inducing an angiogenic switch (28, 29).”
Background
Endogenous Myc maintains the tumor microenvironmentPreprint
Sodir, N. M., Swigart, L. B., Karnezis, A. N., Hanahan, D., Evan, G. I., & Soucek, L. (2011) · Genes & Development · doi:10.1101/gad.2038411 · Cited by 177
Self-citation

Authors: Bergers, G., Brekken, R., McMahon, G., Vu, T. H., Itoh, T., Tamaki, K., Tanzawa, K., Thorpe, P., Itohara, S., Werb, Z., & Hanahan, D.
Affiliations: University of California, San Francisco (US)
Hope Heart Institute (US)
Kyoto University (JP)
Harold C. Simmons Comprehensive Cancer Center (US)
RIKEN Center for Brain Science (JP)
Corresponding author: Hanahan, Douglas
ORCID: Bergers, Gabriele
Brekken, Rolf
Itohara, Shigeyoshi
Werb, Zena
Hanahan, Douglas
Venue: Nature Cell Biology
Publisher: Springer Science and Business Media LLC
Published: 2000-09-20
Volume: 2
Issue: 10
Pages: 737-744
ISSN: 1465-7392 (ISSN-L)
1476-4679
DOI: 10.1038/35036374
PMC: PMC2852586
OpenAlex: W1574172480
Cited by: 2,797
References: 45
Citations by year: 2026: 37 · 2025: 55 · 2024: 76 · 2023: 74 · 2022: 96 · 2021: 90 · 2020: 92 · 2019: 88 · 2018: 82 · 2017: 107 · 2016: 110 · 2015: 98 · 2014: 133 · 2013: 140 · 2012: 137
FWCI: 36.56
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Licence: www.springer.com/tdm (tdm)
Locations: Nature Cell Biology (publishedVersion)
PubMed (publishedVersion)
PubMed Central (acceptedVersion)
Funders: National Cancer Institute (P01CA072006, R01CA057621)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Protease and Inhibitor Mechanisms
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
Keywords: MMP-9, angiogenic switch, vascular endothelial growth factor, VEGF signaling, MMP-2, urokinase, tumor angiogenesis, tumor growth, matrix metalloproteinase inhibitors, SU5416, transgenic mice
MeSH terms: Acetamides, Animals, Cell Transformation, Neoplastic, Genes, Switch, Islets of Langerhans, Lymphokines, Mice, Transgenic, Neovascularization, Pathologic, Pancreatic Neoplasms, Tissue Distribution, Signal Transduction, Endothelial Growth Factors, Receptors, Growth Factor, Matrix Metalloproteinase 9, Receptor Protein-Tyrosine Kinases, Receptors, Vascular Endothelial Growth Factor, Vascular Endothelial Growth Factors, Vascular Endothelial Growth Factor A, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks